To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
Ray 69 worked as a supplier of marketing goodies to the international pharma industry for his whole working life. Retired wealthy by taking candy from the dummies that populate the industry. Even now while they proclaim to know the big pharma model is bust they still haven't got the guts to make the radical jump into the new world
Currently, there is no company profile for ray69.
Currently, there are no blog details for ray69.
Currently, there are no book details for ray69.
AF calls it as he sees it. SRPT rises or falls on results
Oct 28, 2013
I doubt your numbers re pat...
Why A Merck Clinical Trial May Help Amgen And R...
GOOD - Let Indian licencees...
Gilead to license sofosbuvir to Indian drug makers
You can't compare to Sovald...
Why I Bought Into Monday's Move In Regeneron
Your net profit margin of 2...
Biogen: The Pioneer In The Hemophilia A Market
The author misses the whole...
Pfizer Has It All Wrong, Should Look Into New V...
Xignite quote data
© 2014 Seeking Alpha